Macter Launches Hepanox PFS
Summary
Macter International Limited launches Hepanox (Enoxaparin Sodium) Pre-filled syringe, strengthening its biopharmaceuticals portfolio.
Kind of disclosure: Product launch
Read the original filingKey facts
- Launch of Hepanox PFS
- New product in anticoagulant segment
- Compliance with SECP regulations
- Section 96 and 131 of Securities Act, 2015
- Company headquartered in Karachi
- Macter International Limited
Macter International Limited (MACTER) on Nafa
Last price Rs 263.98 · Pharmaceuticals · You can own MACTER shares from your phone.
More MACTER announcements
- NoticePresentation of Corporate Briefing Session
- NoticeNotice of Corporate Briefing Session
- NoticeNotice of Closure of Share Transfer Books For Change of Face Value
- NoticeTransmission of Quarterly Report for the Period Ended September 30, 2026
- NoticeRE-APPOINTMENT OF CHAIRMAN OF THE BOARD AND CHIEF EXECUTIVE OFFICER
- NoticeIntimation of Book Closure for Subdivision of Shares
Source: Macter International Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.